Zydus Takes Aim At Three Rivers' Hep C Patent
Generic drug company Zydus Pharmaceuticals USA Inc. has shot back at drug maker Three Rivers Pharmaceuticals LLC, asserting that its ribavirin caplets and tablets do not infringe Three Rivers' patent for...To view the full article, register now.
Already a subscriber? Click here to view full article